We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · April 15, 2016

Omalizumab for the Treatment of Chronic Spontaneous Urticaria

The Journal of Allergy and Clinical Immunology

 

Additional Info

The Journal of Allergy and Clinical Immunology
Omalizumab for the Treatment of Chronic Spontaneous Urticaria: A Meta-Analysis of Randomized Clinical Trials
J. Allergy Clin. Immunol 2016 Mar 31;[EPub Ahead of Print], ZT Zhao, CM Ji, WJ Yu, L Meng, T Hawro, JF Wei, M Maurer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading